Small cell lung cancer accounts for approximately 15% of bronchogenic carcinomas. It is the
cancer most commonly associated with various paraneoplastic syndromes, including the …

Small cell lung cancer (SCLC) is an aggressive lung tumour strongly associated with
cigarette smoking, with patients often presenting with metastatic disease at the time of …

Background Vascular endothelial growth factor (VEGF) has been implicated in
tumorigenesis and metastasis, and it presumably mediates the proliferation of endothelial …

Treatment options for small cell lung cancer – do we have more choice? | British Journal of
Cancer Skip to main content Thank you for visiting nature.com. You are using a browser …

ABSTRACT IFCT study administering 7.5 mg/kg Bevacizumab plus chemotherapy after
chemotherapy induction did not improve outcomes in extensive SCLC patients. Background …

Lung cancer is the leading cause of cancer-related death in the UK, with small cell histology
accounting for 15%–20% of cases. Small cell lung cancer (SCLC) is initially a …

Qualitätsindikatoren wurden durch Sens et al. wie folgt definiert:„Ein Indikator ist ein
quantitatives Maß, welches zum Monitoring und zur Bewertung der Qualität wichtiger …

Small-cell lung cancer (SCLC) is a disease with a poor prognosis and limited treatment
options. Over the past 30 years, basic and clinical research have translated to little …

Introduction Bevacizumab's role in the treatment of small cell lung cancer (SCLC) is
unknown. A multicenter phase II trial with bevacizumab plus chemotherapy was conducted …

Lung cancer is the leading cause of cancer-related deaths world-wide and small-cell lung
cancer (SCLC) accounts for up to 25% of lung cancer deaths. There has been a …